Inherited predisposition to multiple myeloma

被引:18
|
作者
Koura, Divya T. [1 ]
Langston, Amelia A. [1 ]
机构
[1] Emory Univ, Winship Canc Inst, 1365 Clifton Rd NE,Bldg C-4006, Atlanta, GA 30322 USA
关键词
autoantigens/genetics; genetic predisposition to disease; monoclonal gammopathy of undetermined significance/genetics; multiple myeloma/epidemiology; multiple myeloma/genetics; paraproteins/genetics; phosphorylation/physiology; risk factors; Waldenstrom macroglobulinemia/genetics;
D O I
10.1177/2040620713485375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma ( MM) is the second most common hematologic malignancy in the United States, after non-Hodgkin lymphoma. Family pedigree analyses of high-risk families, case-control studies and racial disparities in disease incidence all point to a potential inherited predisposition to MM. Genome-wide association studies (GWASs) have identified susceptibility loci in a number of cancers and such studies are currently underway in MM. To date, GWASs in MM have identified several potential regions of interest for further study on chromosomes 3p22, 7p15.3, 8q24 and 2p23.3. In addition, several targets of paraproteins (so called 'paratargs') in MM have been identified. Hyperphosphorylation of the paratarg protein, which is inherited in an autosomal dominant manner, appears a common mechanism underlying the antigenicity of these proteins. One particular protein, hyperphosphorylated paratarg-7 (pP-7) is a common target in persons with myeloma and has also been identified in affected members of several high-risk MM families. It appears that the frequency of pP-7 as an antigenic target may be particularly high in African American patients with MM, which could be part of the explanation for observed racial disparities in the incidence of MM. In this review we focus on available data in the area of inherited predisposition to MM, and highlight future research directions.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 50 条
  • [41] HLA GENETICS AND INHERITED PREDISPOSITION TO JRA
    HOWARD, JF
    SIGSBEE, A
    GLASS, DN
    JOURNAL OF RHEUMATOLOGY, 1985, 12 (01) : 7 - 12
  • [42] Predisposition testing for inherited breast cancer
    Cummings, S
    Olopade, O
    ONCOLOGY-NEW YORK, 1998, 12 (08): : 1227 - +
  • [43] Polygenic model of inherited predisposition to cancer
    Dragani, TA
    Canzian, F
    Pierotti, MA
    FASEB JOURNAL, 1996, 10 (08): : 865 - 870
  • [44] Inherited Predisposition to Cancer: Introduction and Overview
    Robson, Mark
    Offit, Kenneth
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (05) : 793 - +
  • [45] Review: Inherited predisposition to prostate cancer
    Bas A.J. Verhage
    Lambertus A.L.M. Kiemeney
    European Journal of Epidemiology, 2003, 18 : 1027 - 1036
  • [46] Management of an inherited predisposition to breast cancer
    Robson, Mark
    Offit, Kenneth
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (02): : 154 - 162
  • [47] INHERITED THROMBOCYTOPENIAS WITH PREDISPOSITION TO HEMATOLOGICAL MALIGNANCIES
    Parrilla Navamuel, L.
    Rodriguez Alen, J. A.
    Figaredo Garcia-Mina, G.
    Daza Pozo, S.
    Albino Salazar, K. G.
    Rollon Simon, N.
    Moreno Ramirez, S.
    Cuesta Tovar, J.
    HAEMATOLOGICA, 2019, 104 : 253 - 253
  • [48] PREIMPLANTATION DIAGNOSIS OF INHERITED PREDISPOSITION TO CANCER
    GULLICK, WJ
    HANDYSIDE, AH
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (13) : 2030 - 2032
  • [49] INHERITED PREDISPOSITION TO LUNG-CANCER
    HASDAY, JD
    MCCREA, KA
    OCCUPATIONAL MEDICINE-STATE OF THE ART REVIEWS, 1992, 7 (02): : 227 - 240
  • [50] INHERITED PREDISPOSITION TO CANCER - DERMATOGLYPHIC STUDY
    FULLER, IC
    BRITISH JOURNAL OF CANCER, 1973, 28 (02) : 186 - 189